Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
The Journal of Infection
|
November 18, 2005
Successful antibiotic treatment of Borreliosis associated pseudolymphomatous systemic infiltrates
A Aigelsreiter, A Pump, W Buchhäusl, et al.
Infection
|
October 22, 2020
Gender differences and influenza-associated mortality in hospitalized influenza A patients during the 2018/19 season
Mario Karolyi, E Pawelka, H Kelani, et al.
Clinical Immunology and Immunopathology
|
September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis
H Burgmann, S Winkler, G J Locker, et al.
The Journal of Hospital Infection
|
April 6, 2015
Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line
J M Aguado, V J Anttila, T Galperine, et al.
The Journal of Hospital Infection
|
August 30, 2008
Evidence-based guidelines for the prevention of ventilator-associated pneumonia: results of a knowledge test among European intensive care nurses
S Labeau, D Vandijck, J Rello, et al.
Infection
|
September 30, 2022
A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
M T Traugott, S Pleininger, S Inschlag-Tisch, et al.
Infection
|
January 13, 2023
Correction: A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
M T Traugott, S Pleininger, S Inschlag-Tisch, et al.
Frontiers in Cardiovascular Medicine
|
March 20, 2024
Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge
J H Niebauer, A Iscel, S Schedl, et al.
Infection
|
June 15, 2020
Successful management of the first reported case in Austria of COVID-19 with ARDS
T Seitz, W Hoepler, L Weseslindtner, et al.
Frontiers in Pharmacology
|
August 8, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
M Karolyi, E Pawelka, S Omid, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
The Journal of Infection
|
November 18, 2005
Successful antibiotic treatment of Borreliosis associated pseudolymphomatous systemic infiltrates
A Aigelsreiter, A Pump, W Buchhäusl, et al.
Infection
|
October 22, 2020
Gender differences and influenza-associated mortality in hospitalized influenza A patients during the 2018/19 season
Mario Karolyi, E Pawelka, H Kelani, et al.
Clinical Immunology and Immunopathology
|
September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis
H Burgmann, S Winkler, G J Locker, et al.
The Journal of Hospital Infection
|
April 6, 2015
Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line
J M Aguado, V J Anttila, T Galperine, et al.
The Journal of Hospital Infection
|
August 30, 2008
Evidence-based guidelines for the prevention of ventilator-associated pneumonia: results of a knowledge test among European intensive care nurses
S Labeau, D Vandijck, J Rello, et al.
Infection
|
September 30, 2022
A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
M T Traugott, S Pleininger, S Inschlag-Tisch, et al.
Infection
|
January 13, 2023
Correction: A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
M T Traugott, S Pleininger, S Inschlag-Tisch, et al.
Frontiers in Cardiovascular Medicine
|
March 20, 2024
Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge
J H Niebauer, A Iscel, S Schedl, et al.
Infection
|
June 15, 2020
Successful management of the first reported case in Austria of COVID-19 with ARDS
T Seitz, W Hoepler, L Weseslindtner, et al.
Frontiers in Pharmacology
|
August 8, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
M Karolyi, E Pawelka, S Omid, et al.
Page
of 11